secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001731122-25-000592
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro receives Nasdaq deficiency notice for low bid price; 180-day cure period
--------------------------------------------------------------------------------

- Notice dated April 14, 2025 for failure to maintain $1 minimum bid price over 30 consecutive business days.
- Initial compliance period ends October 13, 2025; must close at $1.00 for 10 consecutive days.
- If not cured, may qualify for second 180-day period if meeting other listing standards.
- Stock continues trading under symbol RENB; Company evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000592/0001731122-25-000592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000592/e6530_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer